The new drug generates antibodies

"Abu Dhabi Health" provides AstraZeneca to protect patients from "Corona"

“AstraZeneca” is an effective tool to limit the spread of “Covid-19”.

archival

The Abu Dhabi Department of Health, in cooperation with Rafid, announced the provision of the drug AstraZeneca, as part of the national efforts to combat the “Covid-19” virus, so that the UAE will be among the first countries to use this drug that generates antibodies for patients with weak immunity.

This came within the framework of an agreement signed by Rafid Company with AstraZeneca, and in the presence of the Department of Health in Abu Dhabi, as part of a series of new partnerships that the emirate is establishing to strengthen and establish its position as a leading destination for life sciences in the region. Health, logistics and supply chains, to continue its work to develop the capabilities of the medical sector in the Emirate of Abu Dhabi.

AstraZeneca is an effective tool to reduce the spread of "Covid-19", and a solution that guarantees the health and safety of all individuals, regardless of their medical condition.

The new and innovative drug was developed to prevent infection and reduce deaths in patients most at risk of complications and unvaccinated patients.

This agreement comes after the announcement of joint cooperation between the Department of Health and AstraZeneca to enhance ways of joint work in clinical research and establish a digital health system in the emirate to push and support efforts to find innovative solutions that would contribute to meeting health care needs, and consolidate the position of the Emirate of Abu Dhabi as a destination for science and technology. life.

The effective and distinguished response of the Emirate of Abu Dhabi revolves around the health and safety of community members, as this is based on strengthening joint efforts with the most prominent local and international pharmaceutical companies since the beginning of the pandemic.

The department has established a network of supply chains through the Rafid Company, to facilitate the process of providing and distributing AstraZeneca through the distribution center of the Rafid Company, which is the largest and most advanced facility for low-temperature storage in the region.

The Undersecretary of the Department, Dr. Jamal Muhammad Al-Kaabi, said, "This partnership between the public and private sectors to provide the new property represents an achievement added to the country's track record of responding to the pandemic.

The drug will provide protection for immunocompromised patients, who have not been able to receive the vaccine for medical reasons, and will contribute to reducing autoimmune disorders.

The UAE will continue proactive efforts and advance recovery through constructive partnerships at the regional and international levels.”

Follow our latest local and sports news and the latest political and economic developments via Google news